Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques

NeuroImage

Volumn 56, Issue 2, 2011, Pages 788-796

  Rizk Jackson, Angela ^a   Stoffers, Diederick ^d   Sheldon, Sarah ^d   Kuperman, Josh ^b   Dale, Anders ^b   Goldstein, Jody ^b   Corey Bloom, Jody ^b   Poldrack, Russell A ^a,c   Aron, Adam R ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; Huntington's disease; Machine learning; Neuroimaging; Support vector machine; Support vector regression

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; ADULT; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISCRIMINANT ANALYSIS; DISEASE COURSE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; INSULA; LINEAR REGRESSION ANALYSIS; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROIMAGING; PRIORITY JOURNAL; PYRAMIDAL TRACT; SUPPORT VECTOR MACHINE; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; ALGORITHMS; ARTIFICIAL INTELLIGENCE; ASYMPTOMATIC DISEASES; BRAIN; BRAIN MAPPING; COMPUTER SIMULATION; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE DEGENERATION; YOUNG ADULT;

EID: 79955003349     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.04.273     Document Type: Article

References (43)

1. Aron A.R., Shohamy D., Clark J., Myers C., Gluck M.A., Poldrack R.A. Human midbrain sensitivity to cognitive feedback and uncertainty during classification learning. J. Neurophysiol. 2004, 92(2):1144-1152.
2. Aron A.R., Gluck M.A., Poldrack R.A. Long-term test-retest reliability of functional MRI in a classification learning task. Neuroimage 2006, 29(3):1000-1006.
3. Ashburner J., Friston K. Voxel-based morphometry-the methods. Neuroimage 2000, 11(6):805-821.
4. Aylward E., Codori A., Barta P., Pearlson G., Harris G.J., Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch. Neurol. 1996, 53(12):1293-1296.
5. Aylward E.H., Codori A.M., Rosenblatt A., Sherr M., Brandt J., Stine O.C., Barta P.E., Pearlson G.D., Ross C.A. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov. Disord. 2000, 15(3):552-560.
6. Aylward E.H., Sparks B.F., Field K.M., Yallapragada V., Shpritz B.D., Rosenblatt A., Brandt J., Gourley L.M., Liang K., Zhou H., Margolis R.L., Ross C.A. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004, 63(1):66-72.
7. Beglinger L.J., Nopoulos P.C., Jorge R.E., Langbehn D.R., Mikos A.E., Moser D.J., Duff K., Robinson R.G., Paulsen J.S. White matter volume and cognitive dysfunction in early Huntington's disease. Cogn. Behav. Neurol. 2005, 18(2):102-107.
8. Beglinger L., Paulsen J., Watson D., Wang C. Obsessive and compulsive symptoms in prediagnosed Huntington's disease. J. Clin. Psychiatry 2008, 69(11):1758-1765.
9. Bohanna I., Georgiou-Karistianis N., Hannan A.J., Egan G.F. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res. Rev. 2008, 58(1):209-225.
10. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol. Psychiatry 2007, 62(12):1341-1346. of the Huntington Study Group, P.-H. I.
11. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
12. Georgiou-Karistianis N. A peek inside the Huntington's brain: will functional imaging take us one step closer in solving the puzzle?. Exp. Neurol. 2009, 220(1):5-8.
13. Gómez-Ansón B., Alegret M., Muñoz E., Monté G.C., Alayrach E., Sánchez A., Boada M., Tolosa E. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. Parkinsonism Relat. Disord. 2009, 15(3):213-219.
14. Guyon I., Weston J., Barnhill S., Vapnik V. Gene selection for cancer classification using support vector machines. Mach. Learn. 2002, 46(3):389-422.
15. Hersch S.M., Rosas H.D. Neuroprotection for Huntington's disease: ready, set, slow. Neurotherapeutics 2008, 5(2):226-236.
16. Johnstone I.M., Titterington D.M. Statistical challenges of high-dimensional data. Philos. Trans. A Math. Phys. Eng. Sci. 2009, 367(1906):4237-4253.
17. Kipps C.M., Duggins A.J., Mahant N., Gomes L., Ashburner J., McCusker E.A. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J. Neurol. Neurosurg. Psychiatry 2005, 76(5):650-655.
18. Klöppel S., Draganski B., Golding C.V., Chu C., Nagy Z., Cook P.A., Hicks S.L., Kennard C., Alexander D.C., Parker G.J.M., Tabrizi S.J., Frackowiak R.S.J. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008, 131(Pt 1):196-204.
19. Klöppel S., Chu C., Tan G.C., Draganski B., Johnson H., Paulsen J.S., Kienzle W., Tabrizi S.J., Ashburner J., Frackowiak R.S.J. Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology 2009, 72(5):426-431. of the Huntington Study Group, P.-H. I.
20. Knowlton B.J., Mangels J.A., Squire L.R. A neostriatal habit learning system in humans. Science 1996, 273(5280):1399-1402.
21. Langbehn D., Brinkman R., Falush D. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 2004, 65(4):267-277.
22. Marshall J., White K., Weaver M., Wetherill L.F., Hui S., Stout J.C., Johnson S.A., Beristain X., Gray J., Wojcieszek J., Foroud T. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Arch. Neurol. 2007, 64(1):116-121.
23. Paulsen J.S. Functional imaging in Huntington's disease. Exp. Neurol. 2009, 216(2):272-277.
24. Paulsen J., Zimbelman J., Hinton S. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. Am. J. Neuroradiol. 2004, 25(10):1715-1721.
25. Paulsen J.S., Hayden M., Stout J.C., Langbehn D.R., Aylward E., Ross C.A., Guttman M., Nance M., Kieburtz K., Oakes D., Shoulson I., Kayson E., Johnson S., Penziner E. Preparing for preventive clinical trials: the predict-HD study. Arch. Neurol. 2006, 63(6):883-890. of the Huntington Study Group, P.-H. I.
26. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 2006, 59(1):57-63.
27. Pereira F., Mitchell T., Botvinick M. Machine learning classifiers and fMRI: a tutorial overview. Neuroimage 2009, 45(1 Suppl):S199-S209.
28. Ravikumar P., Lafferty J., Liu H., Wasserman L. Sparse additive models. J. R. Stat. Soc. 2009, 71(5):1009.
29. Reading S.A.J., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Pekar J.J., Pearlson G.D., Aylward E., Brandt J., Bassett S.S., Ross C.A. Functional brain changes in presymptomatic Huntington's disease. Ann. Neurol. 2004, 55(6):879-883.
30. Reading S.A.J., Yassa M.A., Bakker A., Dziorny A.C., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Aylward E.H., Brandt J., Mori S., van Zijl P., Bassett S.S., Ross C.A. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Res. 2005, 140(1):55-62.
31. Rosas H.D., Hevelone N.D., Zaleta A.K., Greve D.N., Salat D.H., Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005, 65(5):745-747.
32. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., Salat D.H. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov. Disord. 2006, 21(9):1317-1325.
33. Schölkopf B., Smola A. Learning with Kernels: Support Vector Machines, Regularization, Optimization, and Beyond 2002, MIT Press.
34. Shohamy D., Myers C.E., Grossman S., Sage J., Gluck M.A., Poldrack R.A. Cortico-striatal contributions to feedback-based learning: converging data from neuroimaging and neuropsychology. Brain 2004, 127(4):851-859.
35. Smith S.M., Stefano N.D., Jenkinson M., Matthews P.M. Normalized accurate measurement of longitudinal brain change. J. Comput. Assist. Tomogr. 2001, 25(3):466-475.
36. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., Stefano N.D. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002, 17(1):479-489.
37. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E.J. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006, 31(4):1487-1505.
38. Smola A., Schölkopf B. A tutorial on support vector regression. Stat. Comput. 2004, 14(3):199-222.
39. Stoffers, D., Sheldon, S., Kuperman, J., Goldstein, J., Corey-Bloom, J., Aron, A.R., 2010. Contrasting grey- and white matter changes in preclinical Huntington's disease: an MRI study. Neurology 74 (Apr 13) (15), 1208-1216.
40. Thieben M.J., Duggins A.J., Good C.D., Gomes L., Mahant N., Richards F., McCusker E., Frackowiak R.S.J. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002, 125(Pt 8):1815-1828.
41. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 1998, 57(5):369-384.
42. Wolf R.C., Vasic N., Schönfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007, 130(Pt 11):2845-2857.
43. Zimbelman J.L., Paulsen J.S., Mikos A., Reynolds N.C., Hoffmann R.G., Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J. Int. Neuropsychol. Soc. 2007, 13(5):758-769.